Williamson Legacy Group LLC Cuts Stock Holdings in Tenet Healthcare Co. (NYSE:THC)

Williamson Legacy Group LLC cut its holdings in Tenet Healthcare Co. (NYSE:THC) by 15.5% during the 4th quarter, Holdings Channel reports. The firm owned 4,954 shares of the company’s stock after selling 909 shares during the period. Williamson Legacy Group LLC’s holdings in Tenet Healthcare were worth $625,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. New Wave Wealth Advisors LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter worth about $343,000. Swedbank AB grew its stake in shares of Tenet Healthcare by 100.0% in the fourth quarter. Swedbank AB now owns 40,000 shares of the company’s stock worth $5,049,000 after purchasing an additional 20,000 shares during the last quarter. Signet Financial Management LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter worth about $1,526,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tenet Healthcare in the fourth quarter worth about $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Tenet Healthcare in the fourth quarter worth about $5,892,000. 95.44% of the stock is owned by institutional investors.

Analyst Ratings Changes

THC has been the subject of several research analyst reports. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Tuesday. TD Cowen initiated coverage on shares of Tenet Healthcare in a report on Wednesday. They issued a “buy” rating and a $175.00 price objective for the company. Raymond James lowered shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective for the company. in a report on Friday, November 22nd. JPMorgan Chase & Co. restated an “overweight” rating and issued a $175.00 price objective on shares of Tenet Healthcare in a report on Tuesday, December 17th. Finally, Truist Financial lowered their price objective on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a report on Monday, January 6th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $163.88.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $126.58 on Friday. Tenet Healthcare Co. has a twelve month low of $90.03 and a twelve month high of $171.20. The firm has a market cap of $12.04 billion, a P/E ratio of 3.93, a PEG ratio of 1.02 and a beta of 2.05. The company has a 50 day moving average of $133.03 and a 200 day moving average of $147.07. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, research analysts expect that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.